Evaluation of Proton Pump Inhibitors Prescribing Among Hospitalized Patients: A Cross-Sectional Study

References

• Strand DS, Kim D, Peura DA. 25 years of proton pump inhibitors: a comprehensive review. Gut Liver. 2017;11(1):27–37. doi:10.5009/gnl15502
   PubMed Web of Science ®Google Scholar
• Sachs G, Shin JM, Howden CW. Review article: the clinical pharmacology of proton pump inhibitors. Aliment Pharmacol Ther. 2006;23(Suppl s2):2–8. doi:10.1111/j.1365-2036.2006.02943.x
   PubMedGoogle Scholar
• Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2022;117(1):27–56. doi:10.14309/ajg.0000000000001538
   PubMed Web of Science ®Google Scholar
• Fallone CA, Chiba N, van Zanten SV, et al. The Toronto consensus for the treatment of helicobacter pylori infection in adults. Gastroenterology. 2016;151(1):51–69.e14. doi:10.1053/j.gastro.2016.04.006
   PubMed Web of Science ®Google Scholar
• Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of helicobacter pylori infection. Am J Gastroenterol. 2017;112(2):212–239. doi:10.1038/ajg.2016.563
   PubMed Web of Science ®Google Scholar
• Lanza FL, Chan FK, Quigley EM. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104(3):728–738. doi:10.1038/ajg.2009.115
   PubMed Web of Science ®Google Scholar
• Gralnek IM, Stanley AJ, Morris AJ, et al. Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2021. Endoscopy. 2021;53(3):300–332. doi:10.1055/a-1369-5274
   PubMed Web of Science ®Google Scholar
• Laine L, Barkun AN, Saltzman JR, Martel M, Leontiadis GI. ACG clinical guideline: upper gastrointestinal and ulcer bleeding. ACG. 2021;116(5):899–917.
   Google Scholar
• Boghossian TA, Rashid FJ, Thompson W, et al. Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database Syst Rev. 2017;3(3):Cd011969. doi:10.1002/14651858.CD011969.pub2
   PubMedGoogle Scholar
• Yibirin M, De Oliveira D, Valera R, Plitt AE, Lutgen S. Adverse effects associated with proton pump inhibitor use. Cureus. 2021;13(1):e12759. doi:10.7759/cureus.12759
   PubMed Web of Science ®Google Scholar
• Heidelbaugh JJ, Kim AH, Chang R, Walker PC. Overutilization of proton-pump inhibitors: what the clinician needs to know. Therap Adv Gastroenterol. 2012;5(4):219–232. doi:10.1177/1756283X12437358
   PubMed Web of Science ®Google Scholar
• Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ. 2008;336(7634):2–3. doi:10.1136/bmj.39406.449456.BE
   PubMed Web of Science ®Google Scholar
• Zink DA, Pohlman M, Barnes M, Cannon ME. Long-term use of acid suppression started inappropriately during hospitalization. Aliment Pharmacol Ther. 2005;21(10):1203–1209. doi:10.1111/j.1365-2036.2005.02454.x
   PubMed Web of Science ®Google Scholar
• Yap MH, Yip G, Edwards A, D’Intini V, Tong E. Appropriateness of proton pump inhibitor use in patients admitted under the general medical unit. J Pharm Pract Res. 2019;49(5):447–453. doi:10.1002/jppr.1548
   Google Scholar
• Souaid CK, Maalouf RG, Hallit S, Akiki B, Dagher E. Relevance of proton pump inhibitors prescriptions in a tertiary care hospital in Lebanon. Arab J Gastroenterol. 2020;21(3):194–198. doi:10.1016/j.ajg.2020.07.008
   PubMed Web of Science ®Google Scholar
• Nachnani JS, Bulchandani D, Moormeier J, Foxworth J. Patient and physician predictors of inappropriate acid-suppressive therapy (AST) use in hospitalized patients. J Hosp Med. 2009;4(8):E10–E14. doi:10.1002/jhm.492
   PubMedGoogle Scholar
• Zalloum N, Farha RA, Awwad O, Samara N. Inappropriate prescribing of proton pump inhibitors among patients in two Jordanian tertiary health facilities. Trop J Pharm Res. 2016;15(11):2489. doi:10.4314/tjpr.v15i11.26
   Web of Science ®Google Scholar
• Mohzari YA, Alsaegh A, Basheeruddin Asdaq SM, Al Shanawani SN, Albraiki AA, Bagalb A. The pattern of intravenous proton-pump inhibitor utilization at an academic medical center in Riyadh, Saudi Arabia. J Res Pharm Pract. 2020;9(3):151–154. doi:10.4103/jrpp.JRPP_20_62
   PubMed Web of Science ®Google Scholar
• Gastroenterology ACo. Guidelines - American College of Gastroenterology; 2022. Available from: https://gi.org/guidelines/. Accessed May 1, 2022.
   Google Scholar
• Graham DY, Tansel A. Interchangeable use of proton pump inhibitors based on relative potency. Clin Gastroenterol Hepatol. 2018;16(6):800–808.e807. doi:10.1016/j.cgh.2017.09.033
   PubMed Web of Science ®Google Scholar
• UpToDate. Omeprazole: drug information; 2022. Available from: https://uptodatefree.ir/topic.htm?path=omeprazole-drug-information#F203562. Accessed June 25, 2022.
   Google Scholar
• UpToDate. Pantoprazole: drug information; 2022. Available from: https://uptodatefree.ir/topic.htm?path=pantoprazole-drug-information. Accessed 25, June, 2022.
   Google Scholar
• Grube RR, May DB. Stress ulcer prophylaxis in hospitalized patients not in intensive care units. Am J Health Syst Pharm. 2007;64(13):1396–1400. doi:10.2146/ajhp060393
   PubMed Web of Science ®Google Scholar
• Korayem GB, Alkanhal R, Almass R, et al. Patients, prescribers, and institutional factors associated with inappropriate use of acid suppressive therapy in medical wards: an experience of a single-center in Saudi Arabia. Int J Gen Med. 2021;14:5079–5089. doi:10.2147/IJGM.S328914
   PubMed Web of Science ®Google Scholar
• Abukhalil AD, AbuKhdeir L, Hamed M, et al. Characteristics, risk factors, and prevalence of clostridioides difficile among hospitalized patients in a Tertiary Care Hospital in Palestine. Infect Drug Resist. 2021;14:4681–4688. doi:10.2147/IDR.S333985
   PubMed Web of Science ®Google Scholar
• Elnaem MH, Mohamed MH, Bin Nazar AH. Evaluation of proton pump inhibitors prescribing among non-critically ill hospitalized patients in a Malaysian Tertiary Hospital. J Appl Pharm Sci. 2017;7:83.
   Google Scholar
• Gamelas V, Salvado V, Dias L. Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge. GE Port J Gastroenterol. 2019;26(2):114–120. doi:10.1159/000488506
   PubMedGoogle Scholar
• Liu Y, Zhu X, Li R, Zhang J, Zhang F. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study. BMJ Open. 2020;10(11):e040473. doi:10.1136/bmjopen-2020-040473
   PubMed Web of Science ®Google Scholar
• Abukhalil AD, Nasser A, Khader H, et al. VTE prophylaxis therapy: clinical practice vs clinical guidelines. Vasc Health Risk Manag. 2022;18:701–710. doi:10.2147/VHRM.S382050
   PubMed Web of Science ®Google Scholar
• Marcon Bischoff L, Faraco L, Machado L, Bialecki A, Almeida G, Becker S. Inappropriate usage of intravenous proton pump inhibitors and associated factors in a high complexity hospital in Brazil. Arq Gastroenterol. 2021;58:32–38. doi:10.1590/s0004-2803.202100000-07
   PubMedGoogle Scholar
• Nasser SC, Nassif JG, Dimassi HI. Clinical and cost impact of intravenous proton pump inhibitor use in non-ICU patients. World J Gastroenterol. 2010;16(8):982–986. doi:10.3748/wjg.v16.i8.982
   PubMed Web of Science ®Google Scholar